Le Gal, S.
Publications
P276
Med. Mycol. 2023, 61, myad095.
Atovaquone exposure and Pneumocystis jirovecii cytochrome b mutations: French data and review of the literature.
https://doi.org/10.1093/mmy/myad095
P243
Lancet Respir. Med. 2022, 10, 180-190.
Fungal infections in mechanically ventilated patients with COVID-19 during the first wave: the French multicentre MYCOVID study.
https://doi.org/10.1016/S2213-2600(21)00442-2
P226
J. Mycol. Med. 2020, 30, 100970.
Antifungal susceptibility testing practices in mycology laboratories in France, 2018.
doi: 10.1016/j.mycmed.2020.100970
P214
Diagn. Microbiol. Infect. Dis. 2020, 115004.
Mucorales DNA detection in serum specimens for early diagnosis of mucormycosis.
doi: 10.1016/j.diagmicrobio.2020.115004
Autres publications scientifiques
PS07
Antimicrob. Agents Chemother. 2022, 66, e0156321.
Highly conserved gsc1 gene of Pneumocystis jirovecii in patients with or without prior exposure to ehinocandins.
https://doi.org/10.1128/AAC.01563-21
Brevets
Thèse